Key Insights
  • Blood doping in horses increases red blood cell levels to enhance oxygen delivery, endurance, and recovery
  • Common doping agents include synthetic erythropoietin, cobalt salts, hypoxia stabilizers, and myo-inositol trispyrophosphate
  • Health risks involve anemia, blood thickening, cardiac strain, toxicity, and life-threatening circulatory complications
  • Detection uses blood tests, ELISAs, and mass spectrometry to identify doping biomarkers and banned agents
  • Challenges include micro-dosing, short detection windows, and inconsistent global anti-doping enforcement
  • FEI, USEF, and Equestrian Canada prohibit blood doping and impose fines, suspensions, and disqualifications
  • This banned practice violates animal welfare by prioritizing performance over equine safety and fair competition

Blood doping in horses is a performance-enhancing practice that artificially boosts the blood’s oxygen-carrying capacity by increasing red blood cell (RBC) levels. [1][2][3]

In equestrian sports, blood doping is used to improve stamina, endurance, and recovery, allowing horses to perform at higher intensities for longer durations.

However, blood doping poses serious health risks and ethical concerns. By artificially raising RBC levels, blood doping thickens the blood, which may lead to severe complications, such as blood clots, heart strain, stroke, and even sudden death.

This practice also undermines fair competition and violates animal welfare principles by prioritizing competitive advantage over the horse’s well-being. As a result, blood doping is banned in equestrian sports, with strict regulations in place to detect and prevent its use. [4]

Read on to learn more about blood doping in horses, including the methods, regulations, risks, and challenges associated with this controversial practice.

History of Blood Doping

Blood doping in human sports dates back to the 1960s and 1970s when scientists and athletes experimented with blood transfusions to enhance endurance by increasing oxygen delivery to muscles.

During this period, autologous red blood cell transfusions — injecting an athlete’s own stored blood to boost aerobic efficiency — were also documented in scientific studies. [5][6]

As research explored the effects of red blood cell (RBC) concentration on performance, blood doping became popular in endurance sports such as cycling, cross-country skiing, and long-distance running, where increased oxygen carrying capacity offered a substantial competitive edge.

The practice became even more prevalent in the 1980s with the development of synthetic erythropoietin (EPO), a hormone that naturally stimulates RBC production. Originally intended to treat anemia, EPO quickly found its way into sports as a powerful method to artificially increase RBC levels. [7]

Blood doping in horse sport likely began in the late 20th century, following similar trends seen in human athletics. As high-intensity equine sports like endurance racing and Thoroughbred racing gained popularity, trainers and competitors started using blood doping to enhance stamina and recovery.

Blood Doping Methods

Blood doping enhances athletic performance by increasing the oxygen-carrying capacity of blood, which boosts endurance and reduces fatigue during intense physical activity.

Muscles need oxygen to generate the energy required for movement and contraction. Oxygen is transported to tissues by red blood cells (RBC), each of which can carry a limited number of oxygen molecules. The total oxygen that a horse’s blood can deliver is known as its oxygen-carrying capacity.

By raising red blood cell (RBC) levels, blood doping improves the delivery of oxygen to working muscles, allowing athletes or horses to sustain high-intensity efforts for longer periods during exercise. This increased oxygen availability also aids in faster recovery between exertions, enhancing overall stamina and performance during competition.

Various substances are used in horses to enhance the production or utilization of red blood cells, each targeting different physiological mechanisms. While blood doping encompasses a range of methods and substances, the following are the most studied in horses. However, research on blood doping in horses remains limited.

Synthetic Erythropoietin (rHuEPO)

Erythropoietin (EPO) is a natural hormone that is secreted in the body in response to low blood oxygen levels. Its primary role is to stimulate red blood cell (RBC) production in the bone marrow, increasing the blood’s oxygen-carrying capacity.

This process, known as erythropoiesis, is critical for improving endurance and performance during physical exertion. [7][8]

In horses, recombinant human EPO (rHuEPO), a synthetic version of EPO, is administered to raise RBC levels. This improves oxygen delivery to muscles, enhancing endurance and recovery during races and endurance events. [7][9][10]

However, due to concerns over horse welfare, rHuEPO was banned in equine sports in 2010 as part of broader efforts to regulate performance-enhancing drugs. The Fédération Équestre Internationale (FEI), the governing body for equestrian sports, implemented strict anti-doping measures to protect horse welfare and ensure fair competition. [4][11][12]

Enjoy $10 Off From Us

What's your top priority with your horse's health?

* Limit one per customer
Enjoy $10 Off From Us

Enter your email to receive your store credit

* Limit one per customer

Granulocyte Colony-Stimulating Factor (G-CSF)

Filgrastim (a form of human G-CSF) stimulates the production of certain blood cells. It is often used alongside recombinant human erythropoietin (rhEPO) to treat conditions like anemia or in stem cell treatments.

In horses, trainers may use filgrastim alongside rhEPO to maximize bone marrow cell production. [4] Although it does not boost red blood cell production on its own, identification of this medication may indicate the use of other blood doping agents such as rhEPO.

Hypoxia-inducible factor Modifiers/Stabilizers

Hypoxia-inducible factor (HIF) is a transcription factor that helps the body respond to low oxygen levels (hypoxia). It activates genes that promote oxygen delivery and increase red blood cell production, allowing cells to adapt to oxygen deficiency. [13]

HIF-1 is a key protein in this process, playing a major role in increasing red blood cell production and improving oxygen delivery. HIF-1 modifiers mimic this effect, artificially boosting red blood cell production and oxygen-carrying capacity, which may enhance athletic performance. [7][14]

Common HIF-1 modifiers/stabilizers include cobalt and roxadustat. These substances are banned in equine sports by regulatory bodies such as WADA and IFHA because they have the potential to enhance performance by increasing oxygen availability. [7][14]

Cobalt Chloride

Cobalt chloride (CoCl2) is believed to act as an HIF-1 modifier, stimulating erythropoietin (EPO) production. EPO signals the bone marrow to produce more red blood cells, potentially enhancing the horse’s oxygen-carrying capacity. [15][16][17]

The proposed mechanism of action suggests that cobalt inhibits the breakdown of HIF-1α. Elevated levels of this protein activate the EPO gene in bone marrow, increasing red blood cell formation. [15][16][17]

Although cobalt chloride is occasionally used in racing based on anecdotal reports and preliminary studies, there is currently no scientific evidence that it enhances athletic performance in horses. [2][4][7]

Moreover, high doses of cobalt chloride can be harmful. Although its long-term effects on horses are not well understood, cobalt toxicity has been documented in other species after prolonged exposure, even at low doses. [15][16]

Roxadustat

Roxadustat is a drug that stabilizes hypoxia-inducible factor (HIF), which increases levels of erythropoietin (EPO) and boosts red blood cell production. [14]

Roxadustat is used medically to treat anemia in chronic kidney disease patients. Its use is strictly prohibited in equine sports.

Myo-inositol trispyrophosphate (ITPP)

Myo-inositol trispyrophosphate (ITPP) is a drug that boosts oxygen delivery by improving oxygen release from red blood cells. In horses, it is used to boost stamina, particularly in high-performance disciplines such as racing. [18]

Blood Transfusions & Equestrian Performance

Autologous blood transfusion (ABT) is a blood doping method in humans that involves collecting, storing, and reinfusing the athlete’s own blood before a competition. [19] However, this method is generally ineffective in horses.

Exercise performance relies on the blood’s capacity to deliver oxygen to muscles, which is crucial for converting fats and carbohydrates into energy. VO2max, or maximal oxygen uptake, represents the highest amount of oxygen the body can utilize during intense exercise and is a key indicator of cardiorespiratory fitness and endurance. [20]

Horses naturally have a high VO2max due to anatomical features such as a large heart, high stroke volume (the amount of blood pumped with each beat), and a high concentration of hemoglobin, the oxygen-carrying protein in red blood cells.

Additionally, during exercise, the horse’s spleen contracts to release stored red blood cells into the bloodstream, increasing the oxygen-carrying capacity of the blood to improve performance.

This unique adaptation enables horses to sustain high levels of exertion without requiring external substances to increase their red blood cell count. For this reason, horses are often referred to as “natural blood-dopers,” much like dogs. [20]

Health Risks & Side Effects

Blood doping in horses using substances like cobalt salts and recombinant human erythropoietin (rHuEPO) carries serious health risks. These practices can harm multiple organ systems and severely compromise the horse’s overall well-being.

Complications of blood doping vary based on the substance used and the duration of administration, often linked to increased red blood cells, immune reactions, or toxicity. Affected horses may show: [7][2][16]

  • Lethargy or Fatigue: Despite aiming to boost performance, blood doping can cause adverse effects like anemia or metabolic stress, resulting in reduced energy levels and lethargy
  • Decreased Performance: Also referred to as exercise intolerance, horses may exhibit inconsistent or declining performance, particularly if complications such as anemia or cardiovascular strain occur.
  • Poor Recovery: Delayed recovery may occur due to impaired oxygen transport or cardiovascular stress
  • Arrhythmias: Elevated blood viscosity (thickness) from increased red blood cells can disrupt normal heart function, leading to cardiac arrhythmias (irregular heartbeats)
  • Increased Blood Pressure: Hypertension (high blood pressure) can lead to signs such as restlessness, stress, or discomfort during exercise
  • Decreased Peripheral Circulation: Blood thickening may impair circulation, causing weak distal pulses and other signs of vascular strain
  • Labored Breathing (Dyspnea): Increased blood viscosity can impair oxygen delivery, forcing the horse to breathe harder to meet oxygen demands
  • Anemia: Misuse of rHuEPO can trigger an immune response that destroys both synthetic and natural erythropoietin, leading to severe anemia
  • Pale Mucous Membranes: An indication of anemia or inadequate oxygen delivery to tissues, often observed in the gums, inner eyelids, or nostrils
  • Inflammation: Swelling in joints or systemic inflammation caused by immune system reactions

Cobalt Chloride Toxicity

Cobalt salts used in blood doping for horses pose serious health risks. Cobalt is an essential trace mineral required in the equine diet to support vitamin B12 synthesis, which is important for red blood cell production and overall metabolism.

However, when used in excessive amounts for blood doping, cobalt can cause toxicity, leading to serious complications such as organ damage, cardiac issues, and metabolic disturbances. While research on cobalt’s long-term effects in horses is limited, its toxicity is well documented in humans. [7]

Exposure to toxic dosages of cobalt can cause neurotoxic effects, including optic and auditory neuropathy, and can damage the thyroid, heart, and hematopoietic system. High doses are also linked to fatal heart conditions, such as cardiomyopathy and ischemic heart disease. [2][16][21]

One study in horses showed that intravenous administration of cobalt chloride can lead to irregular blood pressure, signs of distress, and elevated stress markers. Repeated doses may lead to cobalt accumulation in the body, reduced clearance, and long-term damage to multiple systems. [15]

Recombinant Human Erythropoietin (rHuEPO)

The use of rHuEPO in horses to increase red blood cell production carries significant risks. Repeated administration of rHuEPO, which differs structurally from the horse’s natural EPO, can trigger an immune response. [7]

This immune reaction may interfere with the horse’s ability to produce its own EPO, potentially leading to life-threatening anemia. The immune system may attack both the synthetic and natural EPO, reducing the blood’s oxygen-carrying capacity and causing severe health issues. [7]

These risks highlight the dangers of blood doping and emphasize the need for strict regulations to protect the health and well-being of equine athletes.

Intro to Equine Nutrition
Gain a deeper understanding of your horse's nutrition needs. This free introductory course provides a foundation for horse owners to learn how to balance your horse's diet.
Enroll Now
Introduction to Equine Nutrition Course - Mad Barn Academy

Detection of Blood Doping in Horses

Detecting blood doping in horses is paramount for ensuring fair competition, safeguarding the horses’ health and welfare, and upholding the integrity of equine sports.

Effective detection strategies prevent the misuse of performance-enhancing substances by penalizing those who engage in doping. This not only discourages abusers but also reduces the pressure on other competitors to dope their horses.

Advanced techniques like blood tests, immunoassays, and mass spectrometry (LC-MS) are used to detect substances such as recombinant human erythropoietin (rHuEPO) and other doping agents. These methods aim to identify specific biomarkers or metabolites associated with doping.

However, challenges persist, especially with micro-dosing — using small amounts of doping agents to avoid detection. Additionally, some substances have short detection windows because they are quickly metabolized or eliminated, making them harder to detect in post-race or out-of-competition tests. [10]

Available testing methods for blood and plasma analysis include various advanced assays designed to improve detection accuracy, such as: [10][22][23]

  • Erythropoietin (EPO) Testing: Elevated EPO levels in a horse’s blood can indicate the administration of recombinant human EPO (rhEPO)
  • Cobalt Testing: Liquid chromatography-mass spectrometry (LC-MS) can be used to detect cobalt levels in the blood, revealing the use of cobalt salts for doping
  • Hemoglobin and Hematocrit Tests: These tests measure red blood cell counts in the horse’s body; elevated concentrations indicate blood doping with agents like EPO and ITPP
  • Immunoassays (ELISAs): These tests identify specific doping substances, such as filgrastim, by detecting associated proteins or antibodies in the horse’s blood
  • Mass Spectrometry (LC-MS): A highly sensitive method capable of detecting trace amounts of blood doping agents in the blood

Challenges with Doping Control

Enforcing doping regulations in equine sports poses unique difficulties. The Fédération Equestre Internationale (FEI) is the main governing body for international equestrian events, setting standards and rules against performance-enhancing drugs and practices.

Although the FEI has banned all known forms of blood doping, the difficulty in detecting these substances and methods makes enforcement challenging. Advanced doping techniques and limited detection windows allow some violations to go unnoticed.

Furthermore, there is no unified regulatory authority overseeing doping control in horse racing worldwide. This leads to inconsistent anti-doping programs across different regions, making it hard to establish a cohesive system that protects the health and welfare of horses. The lack of standardized regulations hampers efforts to maintain fair competition and safeguard both equine and human participants in the sport.

Anti-Doping Regulations in Equestrian Sports

Major equestrian organizations such as the Fédération Équestre Internationale (FEI), United States Equestrian Federation (USEF), and Equestrian Canada have implemented strict rules to prevent blood doping. These regulations aim to ensure fair competition and protect horse welfare by banning substances and practices that artificially enhance performance. [24]

The FEI maintains a strict stance against blood doping. Under the FEI’s Anti-Doping and Controlled Medication Regulations (ADCMR), the use of performance-enhancing substances — including those used for blood doping — is strictly prohibited. [3]

FEI regulations are aligned with the World Anti-Doping Agency (WADA) standards, and include comprehensive testing procedures for substances that affect red blood cell production and oxygen delivery. These procedures cover both in-competition and out-of-competition testing and involve analyzing blood, urine, and other biological samples. [25]

Penalties for blood doping violations under the FEI are severe. They can include disqualification from events, fines, and suspension of both the horse and responsible individuals, such as trainers, veterinarians, and owners.

Similarly, USEF and Equestrian Canada enforce anti-doping rules that prohibit substances like synthetic erythropoietin (EPO) and blood transfusions. Their testing protocols and penalties align with international standards to maintain the integrity of equestrian competitions and ensure the well-being of horses.

Frequently Asked Questions

Here are some frequently asked questions about blood doping in horses:

Summary

Blood doping in horses is a banned practice that artificially enhances athletic performance by increasing the number of red blood cells in their bloodstream. This boosts endurance and stamina by improving oxygen delivery to muscles.

  • This practice originated in human sports, but is also used in equestrian events through substances like synthetic erythropoietin (rHuEPO) and cobalt chloride
  • Blood doping poses significant health risks to horses, including heart strain, anemia, organ damage, and toxicity
  • Detection methods such as blood tests and mass spectrometry are used to identify doping agents
  • Governing bodies like the FEI, USEF, and Equestrian Canada enforce strict regulations to prevent blood doping in horse sports
Related Articles
Is Your Horse's Diet Missing Anything?

Identify gaps in your horse's nutrition program to optimize their well-being.

References

  1. Jones M. and Tunstall Pedoe D.S., Blood Doping--a Literature Review. Br J Sports Med. 1989.
  2. Mobasheri A. and Proudman C.J., Cobalt Chloride Doping in Racehorses: Concerns over a Potentially Lethal Practice. The Veterinary Journal. 2015.
  3. FEI Equine Anti-Doping and Controlled Medication Regulations. FEI. 2017.
  4. Fragkaki A.G. et al., Challenges in Detecting Substances for Equine Anti-Doping. Drug Testing and Analysis. 2017.
  5. Atkinson T.S. and Kahn M.J., Blood Doping: Then and Now. A Narrative Review of the History, Science and Efficacy of Blood Doping in Elite Sport. Blood Reviews. 2020.
  6. Ekblom B. et al., Response to Exercise after Blood Loss and Reinfusion. J Appl Physiol. 1972.
  7. Wilkin T. et al., Equine Performance Genes and the Future of Doping in Horseracing. Drug Testing and Analysis. 2017.
  8. Robinson N. et al., Erythropoietin and Blood Doping. British Journal of Sports Medicine. 2006.
  9. Elliott S., Erythropoiesis‐stimulating Agents and Other Methods to Enhance Oxygen Transport. British J Pharmacology. 2008.
  10. Dahlgren A.R. et al., Transcriptomic Markers of Recombinant Human Erythropoietin Micro-Dosing in Thoroughbred Horses. Genes. 2021.
  11. Jamieson C.A. et al., Blood Transfusion in Equids—A Practical Approach and Review. Animals. 2022.
  12. FEI announces two banned substance positives. FEI. 2016.
  13. Taylor C.T. and Scholz C.C., The Effect of HIF on Metabolism and Immunity. Nat Rev Nephrol. 2022.
  14. Mathew B. et al., Identification of Hypoxia-Inducible Factor (HIF) Stabilizer Roxadustat and Its Possible Metabolites in Thoroughbred Horses for Doping Control. Drug Test Anal. 2021.
  15. Burns T.A. et al., Effect of Intravenous Administration of Cobalt Chloride to Horses on Clinical and Hemodynamic Variables. Journal of Veterinary Internal Medicine. 2017.
  16. Ho E.N.M. et al., Controlling the Misuse of Cobalt in Horses. Drug Test Anal. 2015. View Summary
  17. Lippi G. et al., Cobalt chloride administration in athletes: a new perspective in blood doping?. British Journal of Sports Medicine. 2005.
  18. Wong A.S.Y. et al., Detection of Myo-Inositol Trispyrophosphate in Equine Urine and Plasma by Hydrophilic Interaction Chromatography-Tandem Mass Spectrometry. Drug Test Anal. 2012.
  19. Grau M. et al., Autologous Blood Doping Induced Changes in Red Blood Cell Rheologic Parameters, RBC Age Distribution, and Performance. Biology. 2022.
  20. Böning D. et al., The Hematocrit Paradox - How Does Blood Doping Really Work?. Int J Sports Med. 2011.
  21. Czarnek K. et al., Selected Aspects of the Action of Cobalt Ions in the Human Body. Cent Eur J Immunol. 2015.
  22. Cavalcanti R.T.C. et al., Detection of ESAs in Equine Urine and Blood by SAR-PAGE. Drug Test Anal. 2019.
  23. Richards S. et al., Enhanced analysis of equine plasma for the presence of recombinant human erythropoietin — Implementation of an improved workflow. Drug Testing and Analysis. 2024.
  24. Equine Medication Control Guide. Equestrian Canada. 2004.
  25. WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST 2022. WADA. 2022.